MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Neurology Residents Versus a Mobile Medical Application in deducing differential diagnoses in Movement Disorders: A multi-center, cross-sectional, observational study

    V. Vishnu, P. Vinny, R. Rajan, V. Goyal, P. Srivastava, V. Lal, P. Sylaja, L. Narasimhan, S. Dwivedi, P. Nair, D. Ramachandran, A. Gupta (New Delhi, India)

    Objective: To test the hypothesis that the differentials generated by the  Mobile Medical Application  are more clinically relevant and complete to the ones derived by…
  • 2019 International Congress

    Impairment of Neurological Ontogenesis in Children with Austism Spectrum Disorders

    V. Kozyavkin, T. Voloshyn (Truskavets, Ukraine)

    Objective: To assess level of involvement of neurological impairment in children with Autism Spectrum Disorders (ASD). Background: Autism Spectrum Disorders are not singly related to…
  • 2019 International Congress

    Non motor symptoms Parkinson’s disease

    N. Bagdanova, Z. Zuleiha (Kazan, Russian Federation)

    Objective: 1.To identify the representation and prevalence of non-motor symptoms of PD in the premotor and early motor stages Background: During the period 2016-2018 104 people were…
  • 2019 International Congress

    Construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)

    KR. Chaudhuri, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, A. Schrag, P. Martinez-Martin (London, United Kingdom)

    Objective: To analyze the construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS). Background: The MDS-NMS is a new instrument that…
  • 2019 International Congress

    Structural connectome of brainstem nuclei in REM sleep behavior disorder, a model of premanifest synucleinopathy

    MG. García-Gomar, LD. Lewis, L. Wald, B. Rosen, A. Videnovic, M. Bianciardi (Boston, MA, USA)

    Objective: To investigate in vivobrainstem structural connectivity changes in a model of premanifest synucleinopathy, REM sleep behavior disorder (RBD), using 7 T high spatial-resolution diffusion-tensor-imaging (DTI)…
  • 2019 International Congress

    The influence of baseline body mass index on cognitive decline in Parkinson’s disease

    SY. Kang, HS. Yoo, SJ. Chung, YH. Sohn, PH. Lee (Seoul, Republic of Korea)

    Objective: The aim of this study is to know whether the baseline BMI is associated with cognitive decline and future development of dementia. Background: Alterations…
  • 2019 International Congress

    Gastrointestinal disorders in various forms of parkinsonism

    R. Matmurodov, KH. Khalimova, EL. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To examine the types of gastrointestinal disorders in parkinsonism, depending on the form of the disease. Background: One of the non-motor autonomic disorders of…
  • 2019 International Congress

    Variations in Olfactory Neural Connections Associated with Cognition in Parkinson’s Disease

    H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)

    Objective: To study the neural connections between orbitofrontal cortex (OFC) and olfactory cortex and analyze their consistency ranging from control group to Parkinson’s Disease (PD)…
  • 2019 International Congress

    Depressive Symptoms are Associated with Lower Locus Coeruleus Volumes in Parkinson’s disease

    C. Farrell, G. Pagano, E. de Natale, M. Politis (London, United Kingdom)

    Objective: To assess locus coeruleus volumes in Parkinson's disease patients with depressive symptoms. Background: Depression associated with Parkinson disease (PD) has a different symptom profile…
  • 2019 International Congress

    Association between sleep disturbances in Parkinson’s disease and bioimaging

    M. Nagai, T. Tsujii, R. Ando, Y. Yamanishi, S. Tada, Y. Hosokawa (Ehime, Japan)

    Objective: We investigated whether bioimaging for Parkinson’s disease (PD) such as metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 123I-ioflupane SPECT (DaTSPECT) are useful for biomarker of sleep…
  • « Previous Page
  • 1
  • …
  • 192
  • 193
  • 194
  • 195
  • 196
  • …
  • 217
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley